Johnson & Johnson Net Worth 2006-2021 | JNJ

Interactive chart of historical net worth (market cap) for Johnson & Johnson (JNJ) over the last 10 years. How much a company is worth is typically represented by its market capitalization, or the current stock price multiplied by the number of shares outstanding. Johnson & Johnson net worth as of January 25, 2022 is $441.3B.
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $441.302B $93.775B
Johnson & Johnson is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. The Company operates in three segments: Consumer, Pharmaceutical, and Medical Devices and Diagnostics. Its Consumer segment offers products for use in the baby care, skin care, oral care, wound care, and women's health fields, nutritional and over-the-counter pharmaceutical products. The company's Pharmaceutical segment provides various products in the areas of anti-infective, antipsychotic, contraceptive, dermatology, gastrointestinal, hematology, immunology, neurology, oncology, pain management, thrombosis, vaccines, and infectious diseases. Its Medical Devices and Diagnostics segment offers electrophysiology and circulatory disease management products; orthopaedic joint reconstruction, spinal care, neurological, and sports medicine products; surgical care, aesthetics, and women's health products. Johnson & Johnson is based in New Brunswick, New Jersey.
Stock Name Country Market Cap PE Ratio
Pfizer (PFE) United States $294.900B 13.97
AbbVie (ABBV) United States $235.193B 10.81
Eli Lilly (LLY) United States $229.066B 28.41
Novo Nordisk (NVO) Denmark $224.083B 29.65
Merck (MRK) United States $200.712B 13.75
Novartis AG (NVS) Switzerland $189.094B 13.61
GlaxoSmithKline (GSK) United Kingdom $119.470B 14.55